US Stock MarketDetailed Quotes

CRDF Cardiff Oncology

Watchlist
  • 5.355
  • -0.395-6.86%
Trading Mar 28 11:09 ET
239.26MMarket Cap-5758P/E (TTM)

Cardiff Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
26.42%488K
21.88%156K
51.61%141K
18.68%108K
12.16%83K
7.52%386K
-3.76%128K
8.14%93K
33.82%91K
2.78%74K
Operating revenue
26.42%488K
21.88%156K
51.61%141K
18.68%108K
12.16%83K
7.52%386K
-3.76%128K
8.14%93K
33.82%91K
2.78%74K
Cost of revenue
Gross profit
Operating expense
13.93%45.9M
10.17%10.49M
20.64%10.96M
16.92%12.32M
8.85%12.14M
37.91%40.29M
-1.44%9.52M
28.26%9.09M
51.42%10.53M
102.18%11.15M
Selling and administrative expenses
-1.05%13.04M
-11.47%2.73M
-4.48%2.94M
39.21%4.3M
-21.75%3.08M
11.34%13.18M
-19.74%3.08M
5.02%3.08M
8.74%3.09M
76.29%3.94M
-General and administrative expense
-1.05%13.04M
-11.47%2.73M
-4.48%2.94M
39.21%4.3M
-21.75%3.08M
11.34%13.18M
-19.74%3.08M
5.02%3.08M
8.74%3.09M
76.29%3.94M
Research and development costs
21.21%32.86M
20.51%7.76M
33.50%8.02M
7.68%8.02M
25.58%9.05M
56.00%27.11M
10.61%6.44M
44.66%6.01M
80.82%7.45M
119.82%7.21M
Operating profit
-13.81%-45.41M
-10.01%-10.33M
-20.32%-10.82M
-16.90%-12.21M
-8.83%-12.05M
-38.28%-39.9M
1.41%-9.39M
-28.51%-8.99M
-51.59%-10.44M
-103.49%-11.07M
Net non-operating interest income expense
157.37%4.07M
36.22%1.01M
133.19%1.07M
316.21%1.05M
623.08%940K
498.86%1.58M
836.71%740K
554.29%458K
256.34%253K
128.07%130K
Non-operating interest income
157.37%4.07M
36.22%1.01M
133.19%1.07M
316.21%1.05M
623.08%940K
498.86%1.58M
836.71%740K
554.29%458K
256.34%253K
128.07%130K
Other net income (expense)
74.41%-98K
71.11%-13K
158.33%21K
101.98%5K
-126.53%-111K
-227.67%-383K
-1,000.00%-45K
-340.00%-36K
-514.75%-253K
-123.79%-49K
Other non- operating income (expenses)
74.41%-98K
71.11%-13K
158.33%21K
101.98%5K
-126.53%-111K
-2,653.33%-383K
---45K
-1,300.00%-36K
---253K
-4,800.00%-49K
Income before tax
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
-54.55%-10.44M
-112.26%-10.99M
Income tax
Net income
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
-54.55%-10.44M
-112.26%-10.99M
Net income continuous Operations
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
-54.55%-10.44M
-112.26%-10.99M
Minority interest income
Net income attributable to the parent company
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
-54.55%-10.44M
-112.26%-10.99M
Preferred stock dividends
0.00%24K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
0.00%24K
0.00%6K
0.00%6K
0.00%6K
0.00%6K
Other preferred stock dividends
Net income attributable to common stockholders
-7.07%-41.47M
-7.35%-9.34M
-13.52%-9.74M
-6.77%-11.16M
-2.09%-11.23M
-36.78%-38.73M
7.89%-8.7M
-23.96%-8.58M
-54.50%-10.45M
-112.13%-11M
Basic earnings per share
-4.49%-0.93
-5.00%-0.21
-10.00%-0.22
-4.17%-0.25
0.00%-0.25
-21.92%-0.89
13.04%-0.2
-17.65%-0.2
-41.18%-0.24
-78.57%-0.25
Diluted earnings per share
-4.49%-0.93
-5.00%-0.21
-10.00%-0.22
-4.17%-0.25
0.00%-0.25
-21.92%-0.89
13.04%-0.2
-17.65%-0.2
-41.18%-0.24
-78.57%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 26.42%488K21.88%156K51.61%141K18.68%108K12.16%83K7.52%386K-3.76%128K8.14%93K33.82%91K2.78%74K
Operating revenue 26.42%488K21.88%156K51.61%141K18.68%108K12.16%83K7.52%386K-3.76%128K8.14%93K33.82%91K2.78%74K
Cost of revenue
Gross profit
Operating expense 13.93%45.9M10.17%10.49M20.64%10.96M16.92%12.32M8.85%12.14M37.91%40.29M-1.44%9.52M28.26%9.09M51.42%10.53M102.18%11.15M
Selling and administrative expenses -1.05%13.04M-11.47%2.73M-4.48%2.94M39.21%4.3M-21.75%3.08M11.34%13.18M-19.74%3.08M5.02%3.08M8.74%3.09M76.29%3.94M
-General and administrative expense -1.05%13.04M-11.47%2.73M-4.48%2.94M39.21%4.3M-21.75%3.08M11.34%13.18M-19.74%3.08M5.02%3.08M8.74%3.09M76.29%3.94M
Research and development costs 21.21%32.86M20.51%7.76M33.50%8.02M7.68%8.02M25.58%9.05M56.00%27.11M10.61%6.44M44.66%6.01M80.82%7.45M119.82%7.21M
Operating profit -13.81%-45.41M-10.01%-10.33M-20.32%-10.82M-16.90%-12.21M-8.83%-12.05M-38.28%-39.9M1.41%-9.39M-28.51%-8.99M-51.59%-10.44M-103.49%-11.07M
Net non-operating interest income expense 157.37%4.07M36.22%1.01M133.19%1.07M316.21%1.05M623.08%940K498.86%1.58M836.71%740K554.29%458K256.34%253K128.07%130K
Non-operating interest income 157.37%4.07M36.22%1.01M133.19%1.07M316.21%1.05M623.08%940K498.86%1.58M836.71%740K554.29%458K256.34%253K128.07%130K
Other net income (expense) 74.41%-98K71.11%-13K158.33%21K101.98%5K-126.53%-111K-227.67%-383K-1,000.00%-45K-340.00%-36K-514.75%-253K-123.79%-49K
Other non- operating income (expenses) 74.41%-98K71.11%-13K158.33%21K101.98%5K-126.53%-111K-2,653.33%-383K---45K-1,300.00%-36K---253K-4,800.00%-49K
Income before tax -7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M-54.55%-10.44M-112.26%-10.99M
Income tax
Net income -7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M-54.55%-10.44M-112.26%-10.99M
Net income continuous Operations -7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M-54.55%-10.44M-112.26%-10.99M
Minority interest income
Net income attributable to the parent company -7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M-54.55%-10.44M-112.26%-10.99M
Preferred stock dividends 0.00%24K0.00%6K0.00%6K0.00%6K0.00%6K0.00%24K0.00%6K0.00%6K0.00%6K0.00%6K
Other preferred stock dividends
Net income attributable to common stockholders -7.07%-41.47M-7.35%-9.34M-13.52%-9.74M-6.77%-11.16M-2.09%-11.23M-36.78%-38.73M7.89%-8.7M-23.96%-8.58M-54.50%-10.45M-112.13%-11M
Basic earnings per share -4.49%-0.93-5.00%-0.21-10.00%-0.22-4.17%-0.250.00%-0.25-21.92%-0.8913.04%-0.2-17.65%-0.2-41.18%-0.24-78.57%-0.25
Diluted earnings per share -4.49%-0.93-5.00%-0.21-10.00%-0.22-4.17%-0.250.00%-0.25-21.92%-0.8913.04%-0.2-17.65%-0.2-41.18%-0.24-78.57%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg